Trials / Unknown
UnknownNCT01012752
A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen Extracts
A Multicenter, Double-Blind, Placebo-Controlled Study With a Modified Allergen Extract for Specific Immunotherapy in Patients With Seasonal Allergic Rhinitis/Rhinoconjunctivitis
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Roxall Medizin · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This trial is performed to evaluate the safety and clinical efficacy of subcutaneous specific immunotherapy in patients suffering from seasonal allergic rhinitis/rhinoconjunctivitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | modified allergen extract | subcutaneous injections |
| BIOLOGICAL | Placebo | subcutaneous injections |
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2017-10-01
- Completion
- 2017-10-01
- First posted
- 2009-11-13
- Last updated
- 2015-11-03
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01012752. Inclusion in this directory is not an endorsement.